Helmut Schumacher Selected Research

Fever (Fevers)

2/2017

Factors associated with efficacy of an ibuprofen/pseudoephedrine combination drug in pharmacy customers with common cold symptoms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Helmut Schumacher Research Topics

Disease

15	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 07/2004
15	Hypertension (High Blood Pressure) 01/2021 - 01/2002
9	Stroke (Strokes) 10/2023 - 07/2004
7	Heart Failure 10/2023 - 07/2004
5	Myocardial Infarction 10/2023 - 07/2004
4	Vascular Diseases (Vascular Disease) 01/2021 - 04/2008
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 10/2020
3	Ischemic Stroke 07/2017 - 02/2010
3	Cough 02/2017 - 04/2008
3	Albuminuria 10/2014 - 07/2009
2	Hemorrhage 01/2021 - 01/2020
2	Atrial Fibrillation 01/2021 - 06/2015
2	Cognitive Dysfunction 03/2015 - 01/2011
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2013 - 10/2011
2	Isolated Systolic Hypertension 01/2013 - 01/2012
2	Type 2 Diabetes Mellitus (MODY) 04/2012 - 10/2011
2	Angioedema 01/2012 - 04/2008
1	Insulin Resistance 10/2023
1	Lower Urinary Tract Symptoms 01/2020
1	Nocturia 01/2020
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2020
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2020
1	Fever (Fevers) 02/2017
1	Rhinorrhea 02/2017
1	Common Cold 02/2017
1	Fatigue 02/2017
1	Headache (Headaches) 02/2017
1	Pain (Aches) 02/2017
1	Sneezing 02/2017
1	Arthralgia (Joint Pain) 02/2017
1	Edema (Dropsy) 01/2014
1	Obesity 01/2013
1	Glucose Intolerance 09/2011
1	Diabetic Nephropathies (Diabetic Nephropathy) 07/2009
1	Proteinuria 08/2008
1	Syncope (Fainting) 04/2008
1	Essential Hypertension 11/2005
1	Pneumonia (Pneumonitis) 03/2003
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 03/2003

Drug/Important Bio-Agent (IBA)

26	Telmisartan (Micardis)FDA Link 01/2021 - 01/2002
13	Ramipril (Altace)FDA LinkGeneric 01/2021 - 07/2004
7	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 09/2014 - 01/2002
6	CreatinineIBA 01/2022 - 07/2009
5	Antihypertensive Agents (Antihypertensives)IBA 01/2013 - 01/2002
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2012 - 07/2004
4	Angiotensin Receptor AntagonistsIBA 09/2011 - 04/2008
3	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 09/2011
3	Amlodipine (Norvasc)FDA LinkGeneric 01/2014 - 08/2010
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 08/2008 - 07/2004
2	AlbuminsIBA 01/2021 - 10/2014
2	DiureticsIBA 01/2020 - 01/2012
2	Warfarin (Coumadin)FDA LinkGeneric 01/2020 - 06/2015
2	hydrochlorothiazide drug combination telmisartanIBA 06/2013 - 11/2005
2	Losartan (Cozaar)FDA LinkGeneric 11/2005 - 01/2002
1	LDL Lipoproteins (beta Lipoproteins)IBA 10/2023
1	oxidized low density lipoproteinIBA 10/2023
1	Triglycerides (Triacylglycerol)IBA 10/2023
1	Dabigatran FDA Link 01/2020
1	Hypnotics and Sedatives (Sedatives)IBA 01/2020
1	Thrombin FDA Link 01/2020
1	Tamsulosin (Flomax)FDA LinkGeneric 01/2020
1	Insulin-Like Growth Factor I (IGF-1)IBA 07/2017
1	Insulin-Like Growth Factor Binding Protein 3IBA 07/2017
1	Insulin (Novolin)FDA Link 07/2017
1	Insulin-Like PeptidesIBA 07/2017
1	Drug CombinationsIBA 02/2017
1	Ibuprofen (Motrin)FDA LinkGeneric 02/2017
1	Pseudoephedrine FDA LinkGeneric 02/2017
1	Vitamin K FDA Link 06/2015
1	telmisartan amlodipine combination FDA Link 01/2013
1	A 7 (A-7)IBA 05/2012
1	SolutionsIBA 05/2012
1	Biomarkers (Surrogate Marker)IBA 01/2012
1	Valsartan (Vals)FDA Link 01/2012
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2012
1	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 01/2012
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2010
1	Dipyridamole (Persantine)FDA LinkGeneric 02/2010
1	Surface-Active Agents (Surfactants)IBA 03/2003
1	Therapeutic UsesIBA 01/2002

Therapy/Procedure

9	Therapeutics 01/2014 - 01/2002
1	Polypharmacy 01/2021